The DEA Told Nicole Huff to Fire Two Employees by Labor Day. She Told the DEA No.

The email arrived on the Thursday before Labor Day. Nicole Huff, who runs Wildflower Medical Dispensary in Aberdeen, Mississippi, a town of about five thousand people in Monroe County, opened a message from Ashlie Way, a diversion investigator in the Drug Enforcement Administration's Jackson District Office. The DEA had run the names on Wildflower's federal registration application. Two of her employees had felony convictions. Huff had until close of business Monday to decide what to do about them. (S1, S2)

The options, as Way laid them out, came to four. Huff could waive her right to expedited processing and apply for employment waivers on the two workers. She could withdraw the application entirely. She could push forward without a waiver and trigger an Order to Show Cause. Or she could take the whole thing to an administrative law judge in Washington, D.C. The one option not on the list was keeping both employees and keeping her place in the fast lane. (S1, S2)

The two workers had been at Wildflower for more than a year. No incidents, no disciplinary actions. Huff has not disclosed what they were convicted of, only that the convictions were nonviolent. She told Marijuana Moment she intends to request waivers for both and, if it comes to it, to argue in front of the judge for a grandfather provision covering anyone employed before the application was filed. (S1)

"I am frustrated and disappointed that, after these two individuals have worked for me for more than a year without any issues or disciplinary actions, the DEA would require me to remove them from their positions," she said. (S1)

This is what the cannabis industry spent a decade asking for, arriving in the form nobody modeled. In April 2026, the Justice Department moved marijuana covered by a state medical license, along with FDA-approved cannabis products, from Schedule I to Schedule III, leaving adult-use cannabis where it was. Nearly 400 operators filed for federal registration before the expedited window closed on June 22. Every one of them is now a prospective DEA registrant, and DEA registrants have been governed since the 1970s by a rule written for hospital pharmacies. (S3, S4)

The text is short and does not bend. A registrant "shall not employ, as an agent or employee who has access to controlled substances, any person who has been convicted of a felony offense" relating to controlled substances, or whose own DEA application was denied, or whose registration was revoked or surrendered for cause. Waivers exist, but only where, in the agency's judgment, "there are valid reasons to believe that diversion is unlikely to occur." The DEA weighs three things: the nature of the offense, how much access to controlled substances the job actually involves, and what security the registrant has in place. (S5)

Whitt Steineker, who co-chairs the cannabis industry team at Bradley Arant Boult Cummings and wrote the first serious legal analysis of the Wildflower matter, made the structural point that the trade coverage has mostly skipped. The April final rule was unusually generous about deferring to state law. Reports and records, order forms, patient certifications standing in for federal prescriptions, labeling, packaging, sealing, disposal, even physical-security requirements: all of it can be satisfied by complying with the state program. Employee eligibility screening was left out. The DEA kept that one. (S5)

There is a reason this rule is going to hit cannabis harder than it ever hit pharmacy. Prohibition produced convictions, and the legal industry hired the people it produced, deliberately and often as a matter of stated policy. Social-equity licensing programs in more than a dozen states are built on the premise that a cannabis conviction should be a qualification for entry rather than a bar to it. Second-chance hiring is not a fringe practice in this business. In much of it, it is the business.

“It is already extremely difficult for individuals with nonviolent felony convictions to obtain stable employment.”

— Nicole Huff, CEO, Wildflower Medical Dispensary

The DEA has not said how many applications it has received or how many are sitting in the same condition as Wildflower's. Asked both questions, the agency did not respond. That silence is the part operators should find unsettling: there is no public denominator. Nobody outside the agency knows whether Huff is an outlier or the first name on a long list. (S1)

The counter-argument deserves to be stated properly, because it is not weak. Section 1301.76 exists to prevent diversion of controlled substances by people with a demonstrated history of diverting controlled substances, and the DEA applies it to every registrant, from a rural pharmacy to a hospital system to a veterinary clinic. The agency did not write a new rule to punish cannabis. It applied an existing one to entities that asked to be let in. Steineker's framing is exact: this is what joining the federal system "actually looks like on the ground: real benefits that arrive alongside real compliance burdens." The industry's complaint for a decade was "let us in." It got in. (S5)

The rebuttal is that the analogy breaks where it matters. A pharmacy technician with a controlled-substance felony was, by definition, convicted of conduct involving the same class of drugs the pharmacy dispenses, under a legal regime that treated that conduct as criminal everywhere. A Mississippi dispensary employee with a marijuana conviction was convicted of doing what Mississippi now licenses her employer to do. Applying one standard to both produces the result Wildflower is living: the state hands you a license to sell cannabis, and the federal government tells you that the people who know the product best are the ones you cannot employ.

Mississippi's structure makes the split unusually visible. The state health department registers patients, certifies practitioners and licenses cultivators and processors. Dispensary licensing runs through a different agency entirely, the Department of Revenue's Alcoholic Beverage Control enforcement division. Neither of them screens employees the way § 1301.76 does. A Mississippi dispensary can be in perfect standing with both state regulators and still be told by a third government that its staffing is disqualifying. (S6)

The program has grown fast enough that the exposure is not theoretical. Mississippi's medical market opened to sales in January 2023 and now runs roughly 175 to 180 active dispensaries serving about 68,000 registered patients, up from 49,626 in 2024 and 66,041 in 2025. That is a lot of retail staff in a state where the median dispensary is a small independent business, not a multistate operator with a compliance department that can absorb an Order to Show Cause. (S7)

The other place this lands is on people rescheduling was supposed to help. Kevin Harden served 14 years of a 30-year federal marijuana sentence before his commutation on September 3. Nothing in the rescheduling order shortened a sentence, and now, as a matter of the same federal regulation Huff is fighting, a commutation does not clear a path into a job at a registered dispensary either. The waiver process is the only door, and it opens at the agency's discretion.

1. Near term, Whether the DEA grants Wildflower's two employment waivers, and on what reasoning. It would be the first public data point on how the agency reads the diversion standard for cannabis retail.
2. If denied, An Order to Show Cause and a hearing before an administrative law judge in Washington, D.C., where Huff says she will argue for a grandfather provision.
3. Watch for, Any DEA guidance or FAQ addressing § 1301.76 in the cannabis registration context. There is none today.
4. Aggregate, Whether the agency ever discloses how many of the roughly 400 applications are delayed over employee criminal records. It has declined to so far.

Huff did not fire anybody by close of business Monday. She is requesting the waivers, and if the waivers are denied she says she will go to Washington and make the argument in front of a judge: that two people who have worked a year without incident at a licensed dispensary in a town of five thousand should not lose their jobs because a rule drafted for hospital pharmacies in 1971 was never revised for a business the federal government spent fifty years pretending did not exist.

Whatever the judge decides applies to everyone else who filed. The industry asked to be let in. It is now finding out which door it walked through.

Keep Reading

Retail Strategy

New York Wired Its Cannabis Debt List Into Metrc. Now a Late Invoice Means Cash at the Door.

Since Sept. 15, a store more than 30 days late on a supplier bill is flagged on the shipping manifest itself, and the state's old reporting portal closed to new reports on Oct. 23. Suppliers call the notice window too short; one state adviser says the real debt is about double what regulators can see.

By Cannabis Inc, Editorial Staff·7 min read

Retail Strategy

Two-Thirds of Missouri's Cannabis Operators Told the DEA No. Their Own Lawyers Disagree About Whether That Was Smart.

Only about a third of MoCannTrade's 90-plus members applied for federal registration, none have been approved, and Treasury still has not said whether registering is what buys you out of Section 280E. Missouri is the control group.

By Cannabis Inc, Editorial Staff·7 min read